Chimeric Antigen Receptors (CARs) are engineered proteins that enable T cells to target specific proteins on cancer cells. These receptors are constructed by combining antigen-recognition domains from antibodies with T cell signaling domains, creating a single receptor capable of both recognizing and killing target cells.
